Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Yuya Miyahara
Mitsubishi Tanabe Pharma Corporation, Japan
Poster(s):
(T1230-02-06) Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Overview
Tuesday, May 14, 2024
12:30 PM – 1:30 PM
PT
(T1430-02-06) Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) C-terminal Lys Clipping
Tuesday, May 14, 2024
2:30 PM – 3:30 PM
PT
(W1330-02-06) Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) Deamidation
Wednesday, May 15, 2024
1:30 PM – 2:30 PM
PT
(W1130-02-06) Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (2) Oxidation
Wednesday, May 15, 2024
11:30 AM – 12:30 PM
PT
